ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

July 17-21, 2021. Philadelphia, PA.

View by Title View by Number View Themes
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: PO126

    D Dimer and other Biomarkers in Dengue Patients within a Doble Viral Circulation Scenery (Dengue/COVID-19)

    F. Chuliber1, R. vanden Ryn2, N. Schutz1,3, L. Barrera2,3, M.S. López2,3, C. Raff2, V. Privitera1, D. Mezzarobba1, M. Villagra Iturre1, V. Estela S1,3, D. Penchasky1,3, G. Jimenez2,3, M. Rolan2, D. Arrigo2,3, J. Arbelbide1,3, F. Seoane2, M. Martinuzzo2,3

  • Abstract Number: PB0045

    D-dimer and the Risk of Diabetes: The REasons for Geographic and Racial Differences in Stroke (REGARDS)

    D. Kamin Mukaz1, D.L. Long2, T.B. Plante1, S.E. Judd2, L.A. McClure3, A.S. Wolberg4, A.P. Carson2, B. Guo2, M. Cushman1

  • Abstract Number: PB0221

    D-dimer as a Predictive Marker for Mortality in Hospitalized COVID-19 Patients

    S. Hassan1,2, B. Ferrari3, R. Rossio4, V. la Mura5, A. Artoni5, F. R. Rosendaal2, R. Gualtierotti1,3, I. Martinelli3, F. Peyvandi1,3, COVID-19 hospital network

  • Abstract Number: LPB0058

    D-dimer Elevation at Time of Admission Is Associated with Need for Ventilator Support among Pediatric Patients with COVID-19 Infection

    N. Wilken1, V. Kostousov1,2, K. Bruzdoski2, S. Sartain3, K. Krum1,2, L. Hensch1,2, J. Teruya1,2, S.-K.R. Hui1,2

  • Abstract Number: PB0258

    D-dimer Increase during Hospitalization is Associated with Negative Outcomes in Patients with COVID-19 Infection

    E. Panchenko1, E. Kropacheva1, A. Komarov1, A. Suvorov1, F. Paveev1, N. Pogosova1, S. Boytson1

  • Abstract Number: PB1235

    D-Dimer Test and Postoperative Thromboprophylaxis

    T. Makarovska Bojadjieva1, E. Velkova1, V. Dejanova Ilijevska1, E. Petkovic1, E. Ristovska1, S. Useini1, R. Grubovic1, M. Tashkovska2, B. Todorovski3

  • Abstract Number: PB1183

    D-dimer to Rule out Venous Thromboembolism during Pregnancy: A Systematic Review and Meta-analysis

    M. Bellesini1,2, H. Robert-Ebadi1, C. Combescure3, C. Dedionigi2, G. Le Gal4, M. Righini1

  • Abstract Number: PB1036

    Dasatinib Impairs Vascular Integrity and Promotes Skin Wound Healing in Mice

    S. Wichaiyo1, S. Svasti2, N. Morales3

  • Abstract Number: PB1243

    DASH Score for Prediction of Recurrent Venous Thromboembolism: Updated Long-term Outcomes from a Single-centre

    A. Banerjee1, M. Berks1, M. Hu1, R. Umeria1, Y. Zhou1, W. Thomas2.

  • Abstract Number: PB0306

    Ddimer and the Correlation with the Mortality Rate in Covid Patients: A Single Centre Report in Medan Indonesia

    S.S. Widjaja1, L. Mutiara2, S. Tan2, F. Fenny2

  • Abstract Number: PB1305

    Deconstructing the Obstetric Antiphopholipid Syndrome (APS)

    B. Grand1, L.S. Voto1

  • Abstract Number: OC 52.4

    Deconstructing the Role of Vessel Wall Architecture on Hemostasis in a Microfluidic Model of Microvascular Bleeding

    M. Sorrells1, K. Neeves1

  • Abstract Number: PB0673

    Decreased Annual Bleeding Rate in Paediatric Patients with Hemophilia a and Inhibitors Treated with Emicizumab vs Bypassing Agents Experience at the National Institute of Pediatrics, Mexico City, Mexico

    M. Nunez Toscano1, N. Lopez-Santiago1, M.d.L. Gonzalez Pedroza1, R. Paredes Aguilera1, G. Tavera Rodriguez1, A. Monsivais Orozco1, K. Maldonado Silva1, A. Bravo Lindoro1

  • Abstract Number: LPB0066

    Decreased Clot Burden is Associated with Factor XIII Val34Leu Polymorphism and Better Functional Outcomes in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis

    I. Szegedi1, R. Orbán-Kálmándi2, A. Nagy3, F. Sarkady2, N. Vasas4, M. Sik4, L. Lánczi4, E. Berényi4, L. Oláh1, L. Csiba5, Z. Bagoly6

  • Abstract Number: PB0401

    Decreased Hepatic Fibrin(ogen) Deposition in a Mouse Model of Failed Liver Regeneration Is Not Associated with Systemic Coagulation Changes

    D. Groeneveld1, L.G. Poole1, H. Cline-Fedewa1, K.S. Baker1, J.P. Luyendyk1

  • Abstract Number: OC 56.1

    Deep Molecular Mechanisms of F8 exon 19 Variants and Translational Approaches in Hemophilia A

    S. Lombardi1, L. Peretto1, S. Merlin2, A. Follenzi2, J.H. McVey3, I. Maestri1, F. Bernardi1, M. Pinotti1, D. Balestra1

  • Abstract Number: OC 43.1

    Deep Mutational Scan of the VWF C Domains to Define Mutations Associated with VWD

    T. Sparring1, K. Singh1, H. Madarati1, C. Kretz1

  • Abstract Number: PB1167

    Deep Vein Thrombosis in Young Woman Reveals a Novel Mutation on SERPINC1 Gene

    F. Bargado1, F. Rincón1, A. Ribeiro1, A. Mascarenhas1, M.C. Romeiras1, T. Araújo1

  • Abstract Number: LPB0127

    Defective Platelet Endocytosis of Albumin in RUNX1 Haplodeficiency Associated with Altered Caveolin-dependent Albumin Trafficking in Megakaryocytic Cells

    F. Del Carpio-Cano1, G. Mao1, MA. Alam1, J. Wurtzel2, L. Goldfinger2, A.K. Rao1

  • Abstract Number: PB1016

    Defining the Molecular Features of Inverse Agonism: Insights from the P2Y12 Receptor and the Antiplatelet Drug Ticagrelor

    S. Bancroft1, J. Khalil1, S. Mundell1

  • Abstract Number: OC 02.3

    Defining Two Separate, but Functional, α-granule Pools in in-vitro-grown Megakaryocytes (MKs): Lessons from Urokinase Plasminogen Activator (uPA)

    S. Zaitsev1, H. Ahn1, M.A. Kowalska1, K. Bdeir2, D.L. French1, R. Camire3, D. Cines2, M. Poncz1, V. Stepanova2

  • Abstract Number: PB0850

    Delayed Diagnosis of Congenital Thrombotic Thrombocytopenic Purpura Presenting as Recurrent Cryptogenic Strokes

    M. Desancho1, M. Beltrami Moreira1

  • Abstract Number: PO172

    Delays of VTE Prophylaxis

    K. Patel1, H. Lombardo1, R. Fulton1, J. Knapp1, T. Knox1, M. Lóser1, A. Hallam2, A. Macchiavelli1,2

  • Abstract Number: OC 58.2

    Delineating the Role of Low Molecular Weight Heparin in Breast Cancer Metastasis

    S.P.S. Dhami1, S. Patmore1, J. Castle2, C.C. Kirwan2,3, J.S. O'Donnell1, J.M. O'Sullivan1

  • Abstract Number: PB0106

    Delivery of a Resuscitation Fluid Cocktail Containing Fibrinogen and Vasopressin as an Infusion Rather than Boluses Improves Hemorrhage in Swine Polytrauma Model

    A. St. John1, X. Wang1, K. Ringgold1, S. Stern1, N. White1

  • Abstract Number: PB0598

    Demographic and Clinical Characteristics of Patients with Hemophilia A in Brazil: Real-world Data from the 6th Interim Analysis of the AHEAD International Study

    M.H. Cerqueira1, C. Ferreira2, C. Lorenzato3, L.E.M. Carvalho4, L.C Oliveira de Oliveira5, I. Pinto6, A. Prezotti7, J. Norton8, L. Tang9, M.C Ozelo10

  • Abstract Number: OC 61.2

    Dense Granules Are Released Cooperatively in Activated Platelets

    T.O. Shepeliuk1,2, A.A. Masaltseva3,4, D.Y. Nechipurenko2,3,4, F.I. Ataullakhanov1,2,3,4, E.L. Grishchuk1

  • Abstract Number: PO155

    Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and Practical Recommendations

    W.E.M. van Dijk1, R.J.J. van Es1, M.E.P. Correa2, R.E.G. Schutgens1, K.P.M. van Galen1

  • Abstract Number: PB0773

    Depression and Anxiety Screening in a Pediatric Coagulation Disorder Program: A Brief Description of a 7-week Pilot

    C. Braunreiter1, E. Marietta1, S. Pentoney1, L. Vanderwal1, B. Kurt1, J. Bowden1

  • Abstract Number: LPB0035

    Desialylation Primes Platelets for Apoptosis: A New Role for ß1 Integrin

    R. Grozovsky1, H. Roweth2, C. Fraser3, K. Sarosiek3, E. Battinelli2

  • Abstract Number: PB0837

    Design of a Phase 3, Randomized, Controlled Study of Prophylactic and On-demand Treatment with Recombinant ADAMTS13 for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura

    N. Jain1, C. Marquez1, L. Martell1

  • Abstract Number: PB0992

    Desipramine Reduces the Exposure of Phosphatidylserine on the Surface of Human Platelets, but Does Not Inhibit Platelet TF-induced Procoagulant Activity

    O. Panes1, M.F. Becerra1, D. Mezzano1

  • Abstract Number: PB0852

    Desmopressin for Reversal of Antiplatelet Drugs in Stroke due to Haemorrhage (DASH): Second Interim Report on Recruitment from a Phase II Double Blind Randomised Controlled Trial

    M. Desborough1,2,3, R. Al-Shahi Salman4, S. Stanworth1,2,5, D. Havard6, P.M Brennan4, R. Dineen6, T. Coats7, T. Hepburn8, L. Woodhouse6, P. Bath6, N. Sprigg6

  • Abstract Number: OC 07.4

    Detection of Joint Effusions in Pediatric Patients with Hemophilia Using Artificial Intelligence-assisted Ultrasound Scanning; Early Insights from the Development of a Self-management Tool

    P. Tyrrell1, V. Blanchette2, M. Mendez3, D. Paniukov3, B. Brand4, M. Zak5, J. Roth6

  • Abstract Number: PB1175

    Detection of Right Ventricular Dysfunction in Acute Pulmonary Embolism by CT Scan: A Systematic Review and Meta-analysis

    N. Chornenki1, K. Poorzargar2, M. Shanjer2, L. Mbuagbaw2, M. Crowther2, A. Delluc3,3, D. Siegal3

  • Abstract Number: PB0129

    Determination of DNA and Histone 3 Plasma Levels for Evaluation of Leukocyte Activation in Plasma of Patients with Peritoneal Carcinomatosis

    S. Mirshahi1,2, J. Soria2, I. Aldybiat2, M. Pocard2, M. Mirshahi2

  • Abstract Number: PB0908

    Developing a Model for Studying von Willebrand Disease with hiPSC-derived Endothelial Cells

    S. de Boer1, R. Dirven1, B. Laan1, J. Eikenboom1

  • Abstract Number: PB0513

    Developing Predictive Models of rFVIII-Fc Half Life for Personalized Prophylaxis in Patients with Hemophilia A

    C.-Y. Chang1,2, S.-W. Lai3, Y.-L. Liu1,2, J.-R. Tsai4, C.-H. Tsai5, C.-N. Cheng6, S.-H. Hu7, J.-T. Ku8, Y.-C. Chen9,7

  • Abstract Number: LPB0096

    Development of a 3D Tissue-engineered Neointimal Model as an Alternative to Animal Models of Human Atherosclerosis

    J. Echrish1,2, Y. Yang3, A. Harper1,3

  • Abstract Number: PB0098

    Development of a Cell-based Assay to Test Factor VIII Internalization Mediated by the Low-density Lipoprotein Receptor (LDLR) and LDLR-related Protein 1 (LRP1)

    H. Chun1, A.G Sarafanov1

  • Abstract Number: PB0432

    Development of a Computable Phenotype for Hospital-associated Bleeding: The Medical Inpatients Thrombosis and Hemostasis (MITH) Study

    M. Gergi1, K. Wilkinson1, I. Koh1, J. Munger1, H. Al-Samkari2, N. Smith3, N.S. Roetker4, M. Cushman1, C. Holmes1, N. Zakai1

  • Abstract Number: PB1200

    Development of a Computable Phenotype for Venous Thrombosis Present on Admission: The Medical Inpatient Thrombosis and Hemostasis (MITH) Study

    R. Thomas1, I. Koh1, K. Wilkinson1, A. Li2, N. Roetker3, N. Smith4, A. Repp1, C. Holmes1, T. Plante1, M. Cushman1, N. Zakai1

  • Abstract Number: PB1241

    Development of a Modified Thrombin Generation Assay with Improved Sensitivity to Factor XIa Inhibition by the Novel Small Molecule Milvexian (BMS-986177/JNJ-70033093)

    M. Bunce1, F. Bonilla1, J. Cardenas2, J. Kotha2, L. Jennings2, M. Chintala1

  • Abstract Number: PB1134

    Development of a Multi-language Mobile App to Implement the 2019 ITAC Clinical Practice Guidelines for the Treatment and Prophylaxis of Venous Thromboembolism in Cancer Patients

    D. Farge1,2,3, C. Frere1,4, J.M. Connors5,6, C. Ay7, A.A. Khorana8, A. Munoz9,10, B. Brenner11, A. Kakkar12,13, H. Rafii1, S. Solymoss (in memoriam)3, D. Brilhante14, M. Monreal15,16, H. Bounameaux17, I. Pabinger7, J. Douketis18

  • Abstract Number: PB1151

    Development of a New Disease-specific Health-related Quality of Life Questionnaire after Deep Vein Thrombosis: Qualitative Phase of a Mixed Method Development

    E. Asady1,2, W. Ghanima2,1,3, L.-P. Jelsness-Jorgensen2,4, F. Klok5, G.J. Boon5, H. Skuterud Wik3

  • Abstract Number: PB0345

    Development of a New ELISA Method for Anti-FVIIa Antibody Measurement

    C. Valsecchi1, L. Schiavone1, H. Behrouz2, Z. Ahsani2, A. Saadatirad2, F. Peyvandi3

  • Abstract Number: PB0878

    Development of a Novel “Arterial Thrombosis-on-a-chip” Microfluidic Device

    J. Berry1, F.J. Peaudecerf2, N.A. Masters3, K.B. Neeves3, R.E. Goldstein4, M.T. Harper1

  • Abstract Number: PB0591

    Development of a Scale in the Diagnosis and Monitoring of Arthropathy in Patients with Hemophilia Using Ultrasound (US) and MRI: Initial Report

    M. Walentowska-Janowicz1, J.B. Ćwikła2,3, M. Brzewski1, M. Matysiak4, P. Łaguna4

  • Abstract Number: PB0397

    Development of an Anti-thrombotic and Anti-inflammatory Coating for Medical Devices

    K. Gonzalez1,2, K. Yu1,2, V. Lei1, E.M. Conway1,2, J.N. Kizhakkedathu1,2,3

  • Abstract Number: OC 50.1

    Development of an Artificial Intelligence Model to Predict Venous Thromboembolic Disease in COVID-19 Patients at Hospital Admission

    M.S. Marcolino1, W.C. Silveira1, B.B.M. Paiva1, C. Valiense1, M.A. Gonçalves1, S.M. Rezende1, M.A.P. Martins1, M.C. Pires1, R.T. Silva1, L.E.F. Ramos1, T.L.S. Sales2, M.V.R.S. Silva1, F. Anschau3, F.A. Botoni4, G.P. Crestani5, K.P.M.P. Martins1, R.L.R. Carvalho1, L.M. Oliveira1, C.A. Polanczyk6

  • Abstract Number: OC 66.4

    Development of an Easy-to-Use ADAMTS13 Conformation Assay Using Fiber Optic Surface Plasmon Resonance Technology

    C. Dekimpe1, Q. Bonnez1, E. Roose1, E. Tellier2, G. Kaplanski2, H.B. Feys3,4, C. Tersteeg1, S.F. De Meyer1, K. Vanhoorelbeke1

  • Abstract Number: PO109

    Development of an Experimental Animal Carotid Artery Model of Thick-cap Fibroatheromatic Plaque with Severe Stenosis (>80%) Using High Power Blue Laser-mediated Thermal Injury and High-cholesterol Diet Injury

    H. Mehrad1,2, A. Sultan- Qurraie3

  • Abstract Number: PB0774

    Development of Decision-making Process to Support Equitable Participant Selection in Pediatric Hemophilia Trials

    K. Hamilton1, K. Strike1, K. Decker1, R. Goldsmith1, T. Almonte1, W. Xie1, M.D Bhatt1, A.K. Chan1

  • Abstract Number: OC 14.3

    Development of Monoclonal Antibodies that Protect FV/FVa from APC-mediated Inactivation for the Treatment of Bleeding

    S. Quinn1, F. Ayombil1, R.M. Camire2

  • Abstract Number: OC 63.2

    Development of Neuro-Fuzzy Networks for Venous Thromboembolism Recurrence Prediction

    G.Y. Ottaiano1, J.M. Annichino-Bizzacchi2, R.M. Filho3, T.D. Martins1

  • Abstract Number: PB0655

    Development of Ordinary Differential Equation-based aPTT and Thrombin Generation Models for Characterizing FIX-Padua Gain of Function

    T. Orfeo1, M. Gissel1, S.J. Everse1, E. Shehu2, R. Corbau2, J.H. Foley2

  • Abstract Number: PB1188

    Diagnosing Deep Venous Thrombosis using Artificial Neural Networks and Metabolomics by 1H-NMR Data

    T.D. Martins1, M. Quintero2,3, L. Tasic3, T.B.B.C. Costa3, D. Stanisic3, S.A.L. Montalvão2, S.C. Huber2, E.V. de Paula2, R.M. Filho4, J.M. Annichino-Bizzacchi2

  • Abstract Number: PB0855

    Diagnosing Heparin-induced Thrombocytopenia Using Machine Learning Algorithms: First Data of the TORADI-HIT Study

    H. Nilius1, J.-D. Studt2, D.A. Tsakiris3, A. Greinacher4, A. Mendez5, A. Schmidt6, W.A. Wuillemin7, B. Gerber8, P. Vishnu9, L. Graf10, T. Bakchoul11, M. Nagler1

  • Abstract Number: OC 21.1

    Diagnosing Inherited Platelet Disorders: Immunofluorescence on the Blood Smear in Comparison with Genetic Testing

    C. Zaninetti1,2, J. Rivera3, E. Leinøe4, E. Zetterberg5, J.M. Bastida6, M. Rossing7, M. Wolff1, C. Freyer1, A. Greinacher1

  • Abstract Number: OC 63.4

    Diagnosis of Acute Pulmonary Embolism across Different Healthcare Settings: A Systematic Review and Individual Patient Data Meta-analysis

    G.-J. Geersing1, T. Takada1, F.A. Klok2, H.R. Büller3, D.M. Courtney4, Y. Freund5, G. Le Gal6, W. Ghanima7, J.A. Kline8, M.V. Huisman2, K.G. Moons1, S. Parpia9, M. Righini10, P.-M. Roy11, M. van Smeden1, M.A. Stals2, P.S. Wells6, K. de Wit9, N. Kraaijpoel3, N. van Es3

  • Abstract Number: PB0337

    Diagnosis of Disseminated Intravascular Coagulation in the Context of Human Immunodeficiency Viral (HIV) Infections in a South African Tertiary Care Setting

    E. Mayne1, A. Mayne1, S. Louw1

  • Abstract Number: PB0937

    Diagnosis of von Willebrand Disease-intricacies and Challenges: An Experience from a Tertiary Care Centre in Southern India

    R. Kar1, K. Balakrishnan1, A. Logaiyappan1, J. Jayachandan1, D. Basu1

  • Abstract Number: PB1184

    Diagnostic Accuracy of D-dimer for Splanchnic Vein Thrombosis: A Systematic Review and Meta-analysis

    L.M. Attard1, K. Vella1, N. Riva1, J. Calleja Agius1, A. Gatt1, A. Squizzato2

  • Abstract Number: LPB0057

    Diagnostic Management of Suspected Pulmonary Embolism in Patients with COVID-19: A Prospective Cohort Study

    M.A.M. Stals1, F.HJ Kaptein1, RHH Bemelmans2, T van Bemmel3, DCW Braeken4, DD Deenstra5, YPA van Dooren6, LM Faber7, MJJH Grootenboers8, LR de Haan9, C Haazer10, A Iglesias del Sol11, S Kelliher12, RI Meijer13, PE Westerweel14, FA Klok1, MV Huisman1, on behalf of the Dutch COVID & Thrombosis Coalition (DCTC)

  • Abstract Number: PB1295

    Diagnostic Significance of Definitions Soluble Fibrin Monomer Complexes In Patients with Preeclampsia

    B. Kurbanov1

  • Abstract Number: LPB0028

    Difference is Risk Factors and Clinical Outcomes in Pediatric Patients with Deep Venous Thrombosis as Compared to Pulmonary Embolism

    S. Suryaprakash1, C. Sabo2, A. Farooqi3, M. Rajpurkar2,3,4

  • Abstract Number: PB1239

    Differences in the Clot Based and Amidolytic Anti-Xa Assays for the Neutralization Profile of Apixaban, Betrixaban, Edoxaban and Rivaroxaban

    F. Siddiqui1, A. Tafur2, D. Hoppensteadt1, E. Bontekoe1, W. Jeske1, B. Lewis1, O. Iqbal1, J. Fareed1

  • Abstract Number: PB0117

    Differences in Thrombin and Plasmin Generation Potential between East African and Western European Adults: The Role of Genetic and Non-genetic Factors

    G.S. Temba1, N. Vadaq1, J. Wan2, V. Kullaya1, D. Huskens2, T. Pecht3, M. Jaeger1, C.K. Boahen1, V. Matzaraki1, W. Broeders1, L. Joosten1, P.G. de Groot1, J. Schultze3, A.J. van der Ven1, V. Kumar1, B.T. Mmbaga4, B. de Laat2, M.G. Netea1, M. Roest2, Q. de Mast1

  • Abstract Number: PB0477

    Differences in Thrombin Generating Capacity in Severe Haemophilia A

    C. Hamid1,2, J. Dunster3, E. Aradom1, J. McVey4, P. Chowdary1,2

  • Abstract Number: PB1211

    Differences of Profile and Management of Cancer-associated Thrombosis in a RIETE’s Hospital in Brazil

    J. de Abreu Couto Vieira1, R. Santos de Oliveira Júnior1, A.T. Cavalcanti Rocha1

  • Abstract Number: PB0191

    Differences of Venous Thromboembolism (VTE) Events in COVID-19 and Non-COVID-19 Hospitalized Patients

    M.C. Chindamo1,2, M.B. Manhaes2, L.D. Carvalho2, G.G. Sardinha2, A.M. Marques2, H.C. Goudar2, A.B. Nunes2, P.R. Carmo Jr1,2, D.R. Salgado1,2

  • Abstract Number: OC 30.4

    Different Profiles of Plasma microRNAs in Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism Related to Occult Cancer

    J. Oto1, O. Tura-Ceide2,3, V. Sánchez-López4, C. Font2, J. Osorio2,3, C. Bonjoch2, D. Hervás5, E. Arellano3, P. Medina1, I. Blanco2,3, V. Peinado2,3, J.A. Barberà2,3, R. Otero3,4

  • Abstract Number: PB1110

    Differential Associations of Aromatase Inhibitors and Tamoxifen with Thrombin Generation and Sensitivity to Thrombomodulin: A Prospective Cohort Study

    M. Blondon1, L. Thouvenin1, T. Lecompte1, M. Righini1, P. Fontana1, A. Bodmer1, A. Casini1

  • Abstract Number: PB0667

    Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as measured by Whole Blood Thromboelastographic Analysis

    S. Mehrotra1, D. Hoppensteadt1, W. Jeske1, O. Iqbal1, A. Tafur2, B. Lewis1, J. Fareed1

  • Abstract Number: PB0910

    Differential Release of VWF and VWF-propeptide from Platelet Alpha-granules

    M. Swinkels1, J. Slotman2, A. Houtsmuller2, F. Leebeek1, J. Voorberg3,4, G. Jansen1, R. Bierings1

  • Abstract Number: NUR 01.7

    Direct Oral Anticoagulants after Bariatric Surgery: A Quality Improvement Project

    J. Bayadinova1, L. Sardo1,2, S. Mithoowani1,2

  • Abstract Number: PB1111

    Direct Oral Anticoagulants vs. Low-molecular-Weight Heparin for the Treatment of Acute Venous Thromboembolism Associated with Gastrointestinal Cancer: A Systematic Review and Meta-analysis

    T. Rungjirajittranon1, W. Owattanapanich1, Y. Chinthammitr1, T. Ruchutrakool1, B. Suwanawiboon1

  • Abstract Number: PB1264

    Direct Oral Factor-Xa-inhibitors for the Treatment of VTE in the Obese: Do Body Weight and Body Composition Matter? A Prospective Pilot Study

    K. Guetl1, D.R. Leitner2, A. Beck2, J. Rabensteiner3, T. Gary1, R.B. Raggam1, H. Toplak2

  • Abstract Number: OC 60.4

    Discovery and in vitro Characterization of an Antibody Fragment (Fab) which Neutralizes Milvexian (BMS-986177/JNJ-70033093)

    Y. Wu1, L. Schneeweis1, J. Pinckney2, C. Terragni2, S. Mai1, Y. An1, J. Gordon2, A. Kozhich1, A.K. Dilger1, W.R. Ewing1, P. Nandi1, J.M. Luettgen1

  • Abstract Number: PB1023

    Discovery of WNT/Planar Cell Polarity Membrane Receptors in Platelets

    S.P Comer1,2, N. Alkazemi1,2, D. Hamilton1,2, T. O'Neill3, P. Maguire1,2,4

  • Abstract Number: PB0636

    Discrepancies in Non-severe Hemophilia A. Experience in a Hemophilia Center in Argentina

    E. Sueldo1, R. Porsella1, L.C.R. Rossetti2, V. Marchione2, P. Radic2, C. De Brasi2, A. Baques1, M. Arias1

  • Abstract Number: PB1169

    Discrepancy between Genotype and Phenotype for Factor V Leiden Mutation in Recipients of Liver and Stem Cell Transplantation

    J. Rigano1

  • Abstract Number: LPB0029

    Distinct Clonal Mutation Patterns between JAK2 V617F Positive and CALR-mutated Essential Thrombocythemia

    R. Fu1, D. Liu2, H. Xiong2, H. Su2, H. Li1, X. Liu1, F. Xue1, S. Zhu2, R. Yang1, T. Cheng1, L. Zhang1

  • Abstract Number: PB0149

    Distinctive Biomarker Features in the Endotheliopathy of Covid-19 and Septic Syndromes

    A.B. Moreno-Castaño1,2,3, S. Fernandez4, M. Palomo5,2,3, J. Martinez-Sanchez5,2,3, S. Torramade-Moix2,3, A. Tellez4, H. Ventosa4, F. Segui4, G. Escolar1,2,3, E. Carreras5,3, J.M. Nicolas4,6, E. Richardson7, D. Garcia-Bernal8, C. Carlo-Stella9, J.M. Moraleda8, P. Richardson10, M. Diaz-Ricart1,2,3, P. Castro4,2,6

  • Abstract Number: PB0870

    Disturbed Platelet Activation in Children with ANKRD26-associated Thrombocytopenia

    D. Polokhov1, D. Fedorova1, A. Pshonkin1, A. Ignatova1, E. Ponomarenko1, M. Aleksenko1, I. Mersiyanova1, E. Seregina1, K. Voronin1, A. Poletaev1, E. Raykina1, M. Panteleev1,2,3,4, P. Zharkov1.

  • Abstract Number: PB0686

    Do New Therapies alter the Treatment of Hemophilia Patients?

    H. Duda1, B. Haschberger1, J. Hesse1, H. Windecker1, A. Hilger1, C. Keipert1

  • Abstract Number: PB0210

    Do Thrombotic and Bleeding Phenotypes Differ in Patients with Severe COVID-19 Compared to Other Viral Pneumonias in the Context of Extracorporeal Membrane Oxygenation?

    A. Weatherill1, M. Gaspar2, M. Passariello3, M. Laffan4, S. Ledot3, D.R. Arachchillage2

  • Abstract Number: PB0200

    Does a National Lockdown Affect the Characterises of Deep Vein Thromboses and Patients in the Community?

    A. Shahid1, N. Aden2, M. Howard1, S. Narayanamoorthi1, T. Khan1

  • Abstract Number: PB1174

    Does Anticoagulation Affect Outcome of Splenic Vein Thrombosis in Acute Pancreatitis?

    L. Vieira1, S. Lopes1, R. Pombal1, R. Neto1, A. Magalhães1, M. Figueiredo1

  • Abstract Number: PB0172

    Does Hydroxychloroquine Prevent Symptomatic Venous Thromboembolism in Patients with Mild to Moderate COVID-19?

    P.-M. Roy1,2,3, V. Dubée4,5, B. Vielle6, O. Blanchet7, J.-M. Lemée8, R. Dhersin4, S. Boucher9,1, C. Belizna10,1, G. Urbanski11,1, O. Sanchez12,13,3, P. Girard14,3, A. Elias15,3, D. Douillet16,1,3, I. Pellier17,5, HYCOVID Study Group

  • Abstract Number: PB0509

    Does Pharmacokinetic-guided Prophylaxis with Antihemophilic Factor (Recombinant) Improve Bleeding Rates over Standard Prophylaxis? Real-world Data from the AHEAD German Study

    R. Klamroth1, A. Huth-Kühne2, K. Kurnik3, C. Escuriola-Ettingshausen4, S. Regensburger5, L. Tang6, J. Norton7, A. Fernandez6, J. Oldenburg8

  • Abstract Number: PB0189

    Does Thromboelastography Predict Clinical Outcomes in COVID-19?

    M. Gaddam1, A. Wahab2, A. Borgert1, S. Frankki1, U. Perepu2, S. Lentz2, L. Rosenstein1

  • Abstract Number: PB0926

    Don’t Let Bleeding Go Unnoticed – A Global Initiative to Increase Awareness of von Willebrand Disease

    F.F. Corrales-Medina1,2, E. Berntorp3

  • Abstract Number: PB0469

    Dose Selection for Subcutaneous Marzeptacog Alfa (Activated) in Subjects with Factor Vll Deficiency Using Population Pharmacometric Clinical Trial Simulations

    A. Faraj1, S. Desai2, L. Neuman2, G.E Blouse2, T. Knudsen2, U.S. Simonsson1

  • Abstract Number: PB0458

    Dose Selection of Marzeptacog Alfa (Activated) in Children with Hemophilia: A Population Pharmacokinetic Exposure Matching Strategy

    A. Faraj1, R. van Wijk1, L. Neuman2, S. Desai2, G.E Blouse2, T. Knudsen2, U.S. Simonsson1

  • Abstract Number: LPB0067

    Drastic Decrease in FVIII Response after Repeated Daily Desmopressin Administrations in Peri-operative Non-severe Hemophilia A Patients: Final Results of Tachyphylaxis in the DAVID and Little DAVID Study

    L.G.R. Romano1, L.M. Schütte1, R.M. van Hest2, K. Meijer3, B.A.P. Laros - van Gorkom4, L. Nieuwenhuizen5, J. Eikenboom6, F.C.J.I. Heubel-Moenen7, N. Uitslager8, M. Coppens9, K. Fijnvandraat10, M.H.E. Driessens11, S. Polinder12, M.H. Cnossen13, F.W.G. Leebeek1, R.A.A. Mahtôt2, M.J.H.A. Kruip1, On behalf of the SYMPHONY Consortium

  • Abstract Number: PB0832

    Drug Induced Purpura in Autologous Hematopoietic Stem Cell Transplantation – A Case Report

    T. Quaresma1, A. Rodrigues1, A. Garção1, C. Malcata2, A. Silva Martins3, A. Cristina Alho3, M. Galvão1

  • Abstract Number: PB0729

    Dual Effect of Hepsin Expression on Tumor Phenotype and Prothrombotic Potential of Colorectal Cancer Cells and Inhibition by Venetoclax

    M.C. Rodenas-Bleda1, J. Peñas-Martínez2,1, D. Zaragoza-Huesca2,1, C. Ortega-Sabater2,1, J. Peña-García3, S. Espín1, G. Ricote1, F. Ayala-de la Peña1,2, G. Luengo-Gil1,2, A. Nieto1, F. García-Molina2, V. Vicente1,2, F. Bernardi4, H. Pérez-Sánchez3, A. Carmona-Bayonas1,2, I. Martínez-Martínez1

  • Abstract Number: OC 72.4

    Durability of Platelet Count Response in Patients Treated with Avatrombopag for Immune Thrombocytopenia (ITP): Post-hoc Results from the Phase 3 Core and Open-label Extension Study

    S. Jain1, M. Wojdyla2, C. Bernheisel2, S. Kolodny2, M. Vredenburg2, T. Gernsheimer3

  • Abstract Number: PB1262

    Duration and Treatment Outcomes between Idiopathic and Provoked Non-catheter-Related Axillary and Subclavian Vein Thromboses

    A. Sliskovic1, M. Vrkic Kirhmajer1, M. Narancic2, I. Sabol3, M. Vodanovic1, A. Boban1, D. Pulanic1

  • Abstract Number: PB1168

    Duration of Thromboprophylaxis with Low Molecular Weight Heparins after Cesarean Delivery in Carriers of Leiden Mutation, F5g1691a Genotype

    M. Nikolaeva1,2, K. Shchekleina1

  • Abstract Number: PB0534

    Dutch Overweight People with Hemophilia Report More Limitations in Activities, but No Association with Sports

    O. Versloot1, E. van Balen2, S. Hassan2, S. Schols3, F. Leebeek4, M. Coppens5, J. Eikenboom2, L. Hooimeijer6, L. van Vulpen1, C. Smit2, M. Driessens7, J. van der Net8, S. Gouw5,2, K. Fischer1, HiN6 steering group

  • Abstract Number: PB0222

    Dynamic Monitoring of Hemostasis and Correction of Heparin Therapy Can Halve the Number of Thrombotic Complications in Patients with Severe COVID-19

    F. Ataullakhanov1,2,3,4,5, S. Shakhidzhanov1, D. Nechipurenko4,1,3, I. Serebrisky6, S. Karamzin1, I. Spiridonov1, D. Zateyshchikov7, M. Panteleev1,3,4,5, V. Mustyatsa3,1, D. Morozova8, E. Koltsova1,3, E. Seregina3,1, S. Ratchina9, A. Gubkin10, A. Martyanov3,1, E. Grishchuk2, D. Protsenko11, C. Tsarenko12, H. Vasilieva13, A. Rumyantsev3

Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley